Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CACA 2025 | Emerging scientific pathways shaping cancer medicine in China

Yongsheng Li • 6 Nov 2025
CACA 2025
General

Yongsheng Li, MD, Chongqing University Cancer Hospital, Chongqing, China, comments on the current state of oncology research and clinical translation in China. National policies have resulted in advances in areas such as tumor immunometabolism and metabolomics, which potentially have clinical implications. This interview took place at the 2025 Chinese Anti-Cancer Association (CACA) Science & Technology Award Talks in Kunming, China.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Related Videos

Implementing the SUPPORT+ symptom monitoring app in routine oncology care
0:46
Implementing the SUPPORT+ symptom monitoring app in routine oncology care
Wing-Lok Chan • 1 Jun 2026
Opportunities & challenges in maintaining a symptom monitoring app in oncology
0:43
Opportunities & challenges in maintaining a symptom monitoring app in oncology
Wing-Lok Chan • 1 Jun 2026
SUPPORT+ digital cancer self-management tool in community settings
2:09
SUPPORT+ digital cancer self-management tool in community settings
Wing-Lok Chan • 1 Jun 2026
Checkpoint inhibitor retreatment after immune-related toxicity
1:01
Checkpoint inhibitor retreatment after immune-related toxicity
Matteo Carlino • 1 Jun 2026
The content of VJOncology is intended for healthcare professionals